Exploring the Links Between Hearing, Cognition and Brain Activity in People With Tinnitus
Launched by INSTITUT PASTEUR · Apr 15, 2025
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand more about tinnitus, which is a condition where people hear ringing or other sounds in their ears that aren’t coming from an outside source. Researchers want to explore how tinnitus affects attention and brain activity compared to people who don’t have tinnitus. By studying these differences, they hope to improve how tinnitus is assessed and find better treatments for those who suffer from it.
To participate in this study, you need to be at least 18 years old and able to understand French. You could be eligible if you have had chronic tinnitus for more than three months or if you do not have tinnitus at all. However, if you have certain medical conditions like neurological disorders, severe hearing loss, or use hearing aids, you would not be able to participate. If you join the study, you can expect to undergo assessments that help researchers learn more about the connection between tinnitus, hearing, and brain function. The study is not yet recruiting participants, so more information will be available soon.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Good written and oral comprehension of the French language
- • Normal or corrected vision
- Group of people with tinnitus :
- • - Chronic tinnitus \> 3 months, uni or bilateral, stable (no period of remission)
- Control group :
- • - No tinnitus
- Exclusion Criteria:
- • Presence of a known neurological disorder
- • Presence of a known degenerative pathology
- • Presence of a known hearing impairment
- • Presence of a motor disability of the upper limbs
- • Severe or profound deafness on one or both sides
- • Person under legal protection (guardianship, curatorship, etc.)
- • Use of hearing aids
About Institut Pasteur
Institut Pasteur is a renowned global research organization dedicated to advancing biomedical science and public health. Established in 1887, it has a rich history of groundbreaking contributions to the understanding and prevention of infectious diseases. The institute conducts innovative clinical trials aimed at developing vaccines, diagnostics, and therapeutic strategies to combat a wide range of health threats. With a multidisciplinary approach and a commitment to collaboration, Institut Pasteur plays a pivotal role in translating scientific discoveries into tangible health solutions, thereby enhancing global health security and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported